Trials / Completed
CompletedNCT04127058
Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
A Safety/Tolerance Study to Evaluate a New Titration Scheme in Patients With Bipolar I Disorder or Schizophrenia
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-center open-label study to be conducted in the United States in subjects with bipolar I disorder or schizophrenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iloperidone | Oral Tablet |
Timeline
- Start date
- 2019-10-07
- Primary completion
- 2019-11-27
- Completion
- 2019-11-27
- First posted
- 2019-10-15
- Last updated
- 2020-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04127058. Inclusion in this directory is not an endorsement.